SU-DHL-2 (ABC-DLBCL model) carried CD37 loss and 25 mutations in kinases or transcription factors, SU-DHL-4 sustained CD37 expression but carried 48 shared mutations in genes encoding for cytokines, kinases, oncogenes, and transcription factors. This evidence concerns the gene CD37 and diffuse large B-cell lymphoma.